Mrna Therapy For The Treatment Of Ocular Diseases

Patent No. EP3122878 (titled "Mrna Therapy For The Treatment Of Ocular Diseases") was filed by Shire Human Genetic Therapies on Mar 19, 2015. The application was issued on Oct 24, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PRUFER & PARTNER MBBJul 24, 2019PRUFER & PARTNER MBB PATENTANWALTE RECHTSANWALTE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3122878

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP15767977A
Filing Date
Mar 19, 2015
Status
Opposition Rejected
Mar 5, 2021
Publication Date
Oct 24, 2018